Chemoinformaics analysis of Trans-Cis-Piperine
| Molecular Weight | 285.343 | nRot | 3 |
| Heavy Atom Molecular Weight | 266.191 | nRig | 19 |
| Exact Molecular Weight | 285.137 | nRing | 3 |
| Solubility: LogS | -4.11 | nHRing | 2 |
| Solubility: LogP | 3.454 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 44.5651 |
| nHD | 0 | BPOL | 25.1109 |
| QED | 0.633 |
| Synth | 2.344 |
| Natural Product Likeliness | 0.125 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.953 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.805 |
| MDCK | 0.0000261 |
| BBB | 0.381 |
| PPB | 0.967904 |
| VDSS | 0.833 |
| FU | 0.0334643 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.715 |
| CYP2c19-inh | 0.668 |
| CYP2c19-sub | 0.505 |
| CYP2c9-inh | 0.282 |
| CYP2c9-sub | 0.642 |
| CYP2d6-inh | 0.836 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.907 |
| CYP3a4-sub | 0.274 |
| CL | 10.873 |
| T12 | 0.655 |
| hERG | 0.639 |
| Ames | 0.816 |
| ROA | 0.629 |
| SkinSen | 0.967 |
| Carcinogencity | 0.804 |
| EI | 0.108 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.255 |
| Antiviral | Yes |
| Prediction | 0.707192 |